Although TNF-neutralizing antibodies are commonly used to treat patients with autoimmune diseases (i.e., RA, IBD, and psoriasis), the efficacy of these drugs with respect to human asthma is not shown [69]. This evidence concerns the gene TNF and inflammatory bowel disease.